<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04591366</url>
  </required_header>
  <id_info>
    <org_study_id>20200369-01H</org_study_id>
    <nct_id>NCT04591366</nct_id>
  </id_info>
  <brief_title>Barrier-Protect Study</brief_title>
  <official_title>Barrier-Protect Study: Do Barrier Dressings Reduce Device Infection: a Pilot, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Heart Institute Research Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effect of an iodine impregnated barrier dressing on device&#xD;
      pocket swab culture positivity. Minimizing contamination during the implant procedure can be&#xD;
      one of the potential improvements to prevent CIED infections. Patients requiring a lead&#xD;
      change, battery change or device upgrade will be eligible. This is a randomized, blinded&#xD;
      study where participants will be randomized to having the barrier dressing applied before any&#xD;
      incision is made (experimental group) or applying the dressing just prior to collecting the&#xD;
      culture swab (control group). Patients and the staff taking the culture swab at the end of&#xD;
      the procedure are blinded as to which group the participant is randomized to.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 15, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2027</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Participants and staff taking the swab will be blinded as to the randomization allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>End of surgery pocket swab culture positivity</measure>
    <time_frame>one month post procedure</time_frame>
    <description>To investigate end of procedure pocket swab culture positivity as a potential surrogate marker of device infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CIED infection, defined as in the recent PADIT trial</measure>
    <time_frame>Year 1 and 2 post procedure</time_frame>
    <description>Pocket infection: Nosocomial surgical site infection will be defined according to the 2008 National Healthcare Safety Network (NHSN) and US CDC definitions for superficial and deep surgical site infections (30)&#xD;
Endocarditis will be diagnosed according to the Modified Dukes' criteria (31). These were adapted by Klug D et al. to diagnose endocarditis in patients with implantable cardiac devices (32).&#xD;
Bloodstream infections will be defined according to 2008 NHSN and US CDC definitions for Primary bloodstream infections (33)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">390</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard skin prep prior to procedure will be performed and an adhesive iodine-infused barrier dressing will be applied post procedure but prior to taking the culture swab and closing the incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard skin prep prior to procedure plus an adhesive iodine-infused barrier dressing prior to incision, post procedure a culture swab will be taken and the incision closed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Barrier dressing</intervention_name>
    <description>A barrier dressing will be applied either pre or post implant prior to a culture swab and closing the incision.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient aged 18&#xD;
&#xD;
          2. Second or later procedure (including pulse generator change, lead revision and device&#xD;
             upgrade procedures) involving manipulation of the pre-existing device pocket.&#xD;
&#xD;
          3. PADIT risk score â‰¥ 5&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unable or unwilling to provide informed consent.&#xD;
&#xD;
          2. De novo device implantation.&#xD;
&#xD;
          3. Active device infection.&#xD;
&#xD;
          4. Iodine allergy&#xD;
&#xD;
          5. Life expectancy less than 2 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alper Aydin, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nancy Page</last_name>
    <phone>613-696-7000</phone>
    <phone_ext>14296</phone_ext>
    <email>nanpage@ottawaheart.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alper Aydin, Dr.</last_name>
    <phone>613-696-7058</phone>
    <email>Aaydin@ottawaheart.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Nancy Page</last_name>
      <phone>613-696-7000</phone>
      <phone_ext>14296</phone_ext>
      <email>nanpage@ottawaheart.ca</email>
    </contact>
    <contact_backup>
      <last_name>Alper Aydin, Dr.</last_name>
      <phone>613-696-7058</phone>
      <email>Aaydin@ottawaheart.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 2, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac</keyword>
  <keyword>Device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

